Cardiac angiogenesis and gene therapy: a strategy for myocardial revascularization.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Current Opinion in Cardiology

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00001573-199911000-00012PMID 10579070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

  1999cited by this paper
• The angiopoietins: Yin and Yang in angiogenesis.

  1999cited by this paper
• Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

  1999cited by this paper
• Increased vascularization in mice overexpressing angiopoietin-1.

  1998cited by this paper
• The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results.

  1998cited by this paper
• Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results.

  1998cited by this paper
• Angiopoietin-1 induces sprouting angiogenesis in vitro.

  1998cited by this paper
• Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

  1998cited by this paper
• Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis.

  1998cited by this paper
• Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.

  1998cited by this paper
• Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion.

  1998cited by this paper
• Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.

  1998cited by this paper
• TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth.

  1998cited by this paper
• Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.

  1998cited by this paper
• Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2*

  1998cited by this paper
• Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial

  1998cited by this paper
• Angiogenesis in Embryos and Ischemic Diseases

  1997cited by this paper
• Comparison of coronary luminal quantification obtained from intracoronary ultrasound and both geometric and videodensitometric quantitative angiography before and after balloon angioplasty and directional atherectomy.

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

  1997cited by this paper
• Regional Angiogenesis Induced in Nonischemic Tissue by an Adenoviral Vector Expressing Vascular Endothelial Growth Factor

  1997cited by this paper
• CAMs and the FGF receptor: an interacting role in axonal growth

  1997cited by this paper
• Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C*

  1997cited by this paper
• Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin.

  1997cited by this paper
• Cytokine Gene Therapy of Cancer Using Gene Gun Technology: Superior Antitumor Activity of Interleukin-12

  1997cited by this paper
• Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia

  1997cited by this paper
• Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector.

  1996cited by this paper
• Shared cell adhesion molecule (CAM) homology domains point to CAMs signalling via FGF receptors.

  1996cited by this paper
• Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart

  1996cited by this paper
• Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia.

  1996cited by this paper
• Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1996cited by this paper
• Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.

  1996cited by this paper
• Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector.

  1996cited by this paper
• Gene therapy for ischemic heart disease.

  1996cited by this paper
• Vascular endothelial growth factor B, a novel growth factor for endothelial cells.

  1996cited by this paper
• Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.

  1996cited by this paper
• Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model.

  1996cited by this paper
• Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo.

  1996cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Gene therapy in heart disease.

  1995cited by this paper
• Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.

  1995cited by this paper
• Transfer of Genes to Humans: Early Lessons and Obstacles to Success

  1995cited by this paper
• A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

  1995cited by this paper
• Fibroblast growth factors: at the heart of angiogenesis.

  1995cited by this paper
• Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart.

  1995cited by this paper
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: Implications for potentiation of growth factor action by heparin

  1995cited by this paper
• Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?

  1995cited by this paper
• Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA.

  1995cited by this paper
• Potential gene therapy strategies in the treatment of cardiovascular disease.

  1995cited by this paper
• Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.

  1994cited by this paper
• Basic fibroblast growth factor enhances myocardial collateral flow in a canine model.

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Angiogenesis and colonization in the tumor metastatic process: basic and applied advances

  1994cited by this paper
• Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

  1994cited by this paper
• Vascular endothelial growth factor and its receptors.

  1994cited by this paper
• Gene transfer and vascular disease.

  1994cited by this paper
• Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

  1994cited by this paper
• Safety and efficacy of repetitive adenovirus–mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats

  1994cited by this paper
• Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor.

  1994cited by this paper
• Cell Signalling: Do adhesion molecules signal via FGF receptors?

  1994cited by this paper
• Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.

  1994cited by this paper
• The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

  1993cited by this paper
• Growth factors in endothelial regeneration.

  1993cited by this paper
• Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice.

  1992cited by this paper
• Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

  1992cited by this paper
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

  1992cited by this paper
• Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice

  1992cited by this paper
• bFGF enhances the development of the collateral circulation after acute arterial occlusion.

  1992cited by this paper
• In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.

  1992cited by this paper
• Transplantation of Genetically Modified Autologous Hepatocytes into Nonhuman Primates: Feasibility and Short-Term Toxicity

  1992cited by this paper
• Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor.

  1992cited by this paper
• 1992 MACK FORSTER AWARD LECTURE REVIEW

  1992cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

  1991cited by this paper
• Regulators of angiogenesis.

  1991cited by this paper
• Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• The vascular endothelial growth factor family of polypeptides

  1991cited by this paper
• Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits.

  1991cited by this paper
• Expression of recombinant genes in myocardium in vivo after direct injection of DNA.

  1990cited by this paper
• Site-specific integration by adeno-associated virus.

  1990cited by this paper
• Angiogenic growth factors.

  1990cited by this paper
• Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

  1990cited by this paper
• Site-specific integration by adeno-associated virus.

  1990cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

  1989cited by this paper
• Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells.

  1989cited by this paper
• The heparin-binding (fibroblast) growth factor family of proteins.

  1989cited by this paper
• Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

  1989cited by this paper
• Vascular permeability factor, an endothelial cell mitogen related to PDGF.

  1989cited by this paper
• Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells.

  1989cited by this paper
• Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family.

  1989cited by this paper
• Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types

  1988cited by this paper
• Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells

  1988cited by this paper
• Collateral blood supply to the myocardium at risk in human myocardial infarction: a quantitative postmortem assessment.

  1988cited by this paper
• Regulation of adeno-associated virus DNA replication.

  1988cited by this paper
• A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication

  1987cited by this paper
• Structural characterization and biological functions of fibroblast growth factor.

  1987cited by this paper
• High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.

  1984cited by this paper

• Reduced Gja5 expression in arterial endothelial cells impairs arteriogenesis during acute ischemic cardiovascular disease.

  2017cites this paper
• to hypoxia or expressing a hybrid form of HIF-1 Gene expression profiles in human cardiac cells subjected

  2016cites this paper
• α HIF-1to hypoxia or expressing a hybrid form of Gene expression profiles in human cardiac cells

  2015cites this paper
• Gene therapy for ischemic heart disease: review of clinical trials.

  2011cites this paper
• Terapia gênica para cardiopatia isquêmica: revisão de ensaios clínicos Gene therapy for ischemic heart disease: review of clinical trials

  2011cites this paper
• Terapia gênica para cardiopatia isquêmica: review of clinical trials

  2011cites this paper
• Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1

  2009cites this paper
• Determinación de la densidad y heterogeneidad de la angiogénesis en la valvulitis crónica reumática

  2009cites this paper
• Nonviral Technologies for Gene Therapy in Cardiovascular Research

  2008cites this paper
• Journeys in Coronary Angiogenesis

  2008cites this paper
• Terapia angiogénica en el tratamiento de la cardiopatía isquémica

  2007cites this paper
• Angiogenic therapy in the ischemic cardiopathy treatment

  2007cites this paper
• Ultrasound-based and Non-viral Technologies in Gene Therapy

  2007cites this paper
• Gene transfer therapy in vascular diseases.

  2006cites this paper
• Angiogenic and antiangiogenic gene therapy

  2005cites this paper
• Bone marrow stem cell treatment in heart failure patients

  2005cites this paper
• Experimental and Clinical Studies

  2005cites this paper
• Stimulation der endogenen Kollateralisierung im chronisch ischämischen Myokard durch Therapie mit Wachstumsfaktoren

  2005cites this paper
• Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation

  2004cites this paper
• Myocardial angiogenesis induced by plasmid VEGF-A165 gene transfer : Experimental and clinical studies

  2004cites this paper
• Analysis of VEGF-responsive Genes Involved in the activation of endothelial cells

  2003cites this paper
• Alternative therapeutic strategies for patients with severe end‐stage coronary artery disease not amenable to conventional revascularization

  2003cites this paper
• Angiogenesis of the heart

  2003cites this paper
• Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.

  2002cites this paper
• Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1α

  2002cites this paper
• Therapeutic angiogenesis: a fantastic new adventure.

  2002cites this paper
• Therapeutic Angiogenesis for Coronary Artery Disease

  2002cites this paper
• Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha.

  2002cites this paper
• Förderung der Arteriogenese

  2002cites this paper
• L'angiogenèse : une nouvelle technologie pour le traitement de la coronaropathie

  2001cites this paper
• Signalling pathways downstream of vascular endothelial growth factor receptors

  2001cites this paper
• Transmyocardial laser revascularization dose response: enhanced perfusion in a porcine ischemia model as a function of channel density.

  2001cites this paper
• Therapeutic angiogenesis for ischemic cardiovascular disease.

  2001cites this paper
• Angiogenesis: protein, gene, or cell therapy?

  2001cites this paper
• Angiogenesis: An emerging technology for the treatment of coronary artery disease

  2001cites this paper
• Gene Therapy for Ischemic Heart Disease

  2001cites this paper
• Receptor-Mediated Gene Targeting to Tissues In Vivo Following Intravenous Administration of Pegylated Immunoliposomes

  2001cites this paper
• Downregulation of CXCR4 gene expression in primary human endothelial cells following infection with E1(-)E4(+) adenovirus gene transfer vectors.

  2000cites this paper
• The pathophysiology of the collateral circulation (arteriogenesis)

  2000cites this paper
• isquêmica : revisão de ensaios clínicos Gene therapy for ischemic heart disease : review of clinical trials

  year unknowncites this paper